Works about HYDROXYUREA


Results: 806
    1
    2
    3
    4
    5
    6

    Imatinib in combination with hydroxyurea versus hydroxyurea alone as oral therapy in patients with progressive pretreated glioblastoma resistant to standard dose temozolomide.

    Published in:
    Journal of Neuro-Oncology, 2010, v. 96, n. 3, p. 393, doi. 10.1007/s11060-009-9976-3
    By:
    • Dresemann, Gregor;
    • Weller, Michael;
    • Rosenthal, Mark A.;
    • Wedding, Ulrich;
    • Wagner, Wolfgang;
    • Engel, Erik;
    • Heinrich, Bernhard;
    • Mayer-Steinacker, Regine;
    • Karup-Hansen, Anders;
    • Fluge, Øystein;
    • Nowak, Anna;
    • Mehdorn, Maximilian;
    • Schleyer, Eberhard;
    • Krex, Dietmar;
    • Olver, Ian N.;
    • Steinbach, Joachim P.;
    • Hosius, Christian;
    • Sieder, Christian;
    • Sorenson, Greg;
    • Parker, Richard
    Publication type:
    Article
    7
    8
    9
    10
    11
    12

    Melanoniquia debida a hidroxiurea.

    Published in:
    Acta Médica Peruana, 2024, v. 41, n. 2, p. 144, doi. 10.35663/amp.2024.412.2861
    By:
    • Pamo-Reyna, Oscar G.
    Publication type:
    Article
    13
    14
    15
    16
    17

    In-Depth Immunological Typization of Children with Sickle Cell Disease: A Preliminary Insight into Its Plausible Correlation with Clinical Course and Hydroxyurea Therapy.

    Published in:
    Journal of Clinical Medicine, 2022, v. 11, n. 11, p. 3037, doi. 10.3390/jcm11113037
    By:
    • Giulietti, Giulia;
    • Zama, Daniele;
    • Conti, Francesca;
    • Moratti, Mattia;
    • Presutti, Maria Teresa;
    • Belotti, Tamara;
    • Cantarini, Maria Elena;
    • Facchini, Elena;
    • Bassi, Mirna;
    • Selva, Paola;
    • Magrini, Elisabetta;
    • Lanari, Marcello;
    • Pession, Andrea
    Publication type:
    Article
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37

    Scleroderma-like syndrome due to hydroxyurea.

    Published in:
    Clinical & Experimental Dermatology, 2012, v. 37, n. 7, p. 755, doi. 10.1111/j.1365-2230.2011.04326.x
    By:
    • García-Martínez, F. J.;
    • García-Gavín, J.;
    • Álvarez-Pérez, A.;
    • Alonso-González, J.;
    • Ginarte, M.;
    • Toribio, J.
    Publication type:
    Article
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50